Population
Postmyocardial infarction patients with ventricular arrhythmias
Design
Review
Authors
Loading...
Endorses beta-blockers for post-MI complex VPBs while avoiding Class I agents; confirms trial evidence guiding VT/VF therapy.
This review highlights that beta-blockers are beneficial for post-MI ventricular arrhythmias, Class I antiarrhythmics are harmful, and high-risk patients with sustained VT/VF or nonsustained VT with LV dysfunction require targeted therapies like ICDs or amiodarone.
L. Brent Mitchell (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: